Skip to content

Half effective dose of esketamine combined with low-dose Sufentanil for MPR of Burn Scar in children

Half effective dose of esketamine combined with low-dose Sufentanil for MPR of Burn Scar in children

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054524
Enrollment
Unknown
Registered
2021-12-19
Start date
2021-12-21
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn scars in children

Interventions

Experimental group:Esketamine

Sponsors

Jinan Central Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: 1. Patients with burn scars who are to be treated with micro-plasma beams under intravenous general anesthesia; 2. ASA classification level I; 3. Aged 0 to 14 years.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to esketamine, sufen, propofol and any components of this product; 2. History of severe asthma, history of mental and neurological diseases, recent symptoms of respiratory tract infection, etc.; 3. Changes in surgery or anesthesia methods; 4. Currently using sedatives (such as propofol, morphine, fentanyl, sufentanil, midazolam, dexmedetomidine, ketamine) or have recently used sedatives (withdrawal time <24h).

Design outcomes

Primary

MeasureTime frame
Body movement response;

Secondary

MeasureTime frame
blood pressure;Heart rate;Percutaneous Oxygenation;

Countries

China

Contacts

Public ContactChi Wenying

Jinan Central Hospital Affiliated to Shandong University

wenyingchi1988@163.com+86 18654557772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026